Skip to Main Content

Paper Details

Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies.
Blood
7
2022
Author NameAffiliation
Francisco VegaThe University of Texas MD Anderson Cancer Center.
  • 1 - 1

Datasets

Release 1.2